Search research articles
Contact Us
Filters
Showing results (71-80 of 73) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 73 results.
European Urology
|
August 31, 2001
Methods for measuring crystallization in urolithiasis research: why, how and when?
B Hess, R L Ryall, J P Kavanagh, et al.
Kidney International
|
March 1, 1996
Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix
A M Stapleton, C J Dawson, P K Grover, et al.
Clinical Science (London, England : 1979)
|
November 1, 1995
The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro
R L Ryall, P K Grover, A M Stapleton, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 73) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 73 results.
European Urology
|
August 31, 2001
Methods for measuring crystallization in urolithiasis research: why, how and when?
B Hess, R L Ryall, J P Kavanagh, et al.
Kidney International
|
March 1, 1996
Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix
A M Stapleton, C J Dawson, P K Grover, et al.
Clinical Science (London, England : 1979)
|
November 1, 1995
The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro
R L Ryall, P K Grover, A M Stapleton, et al.
Page
of 8